Navigation Links
Ralph Kauten on how to raise angel financing

Ralph Kauten. Source: Teresa Esser.
Ralph is one of the most successful entrepreneurs in the state, in the field of bioscience, said Frank Langley, president and CEO of Point One Personal Genetic Systems.

But youll never get Ralph Kauten to admit that his success in high-tech entrepreneurship is somehow related to his own efforts.

Ive been ......

Full article >>> Kauten founded PanVera, some professors from the University of Wisconsin-Madison approached him about starting a new gene-transfer company, called Mirus Corporation. Kauten never joined Mirus Corporation as an employee, but he served as chairman of the board and advisor. After helping the professors write their business plan, Kauten helped Mirus raise $700,0......

Full article >>> ity that is being placed in you, Kauten said. Being trustworthy means saying what you are going to do, and then finding a way to do what you said.

If people dont know you, theyre not going to invest in you.
Kauten believes that it is important for entrepreneurs to keep their investors interests in mind when making business decisions. People have entrusted you w......

Full article >>> et="blank" href=" http://www.theventurecafe.com/">The Venture Caf. She can be reached at teresa@wistechnology.com.

The opinions expressed herein or statements made in the above column are solely those of the author, & do not necessarily reflect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or re......

Full article >>>
'"/>

Source:wistechnology.com By Teresa Esser 10/03/04


Related biology technology :

1. TomoTherapy raises $223 million in IPO
2. Biotech officials praise focus of new venture fund
3. Investors raise $25 million for biodiesel plant
4. ZyStor seeks to raise $15M for clinical trials
5. Fusion 2007: CA chief says IT complexity raises risk
6. Fusion 2007: CEOs say bar is raised for CIOs
7. Inline intellectual property raises legal issues
8. Biotech with Madison ties raises $21M in capital
9. Third Wave Technologies to raise $14.9M through private debt
10. ConjuGon raises $3.3 million to fund clinical trials
11. Nerites raises $1 million to improve medical tech
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... GREENWOOD VILLAGE, Colo. , March 23, 2017 /PRNewswire/ ... million in Series A financing and note conversion to ... products. Cool Planet is focused on developing products that ... raised nearly $30 million in the last 18 months. ... Coppel and North Bridge Venture Partners. ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
(Date:3/22/2017)... ... , ... Premier executive recruitment firm, Slone Partners, is proud to have been ... , Hunt Scanlon Media is one of the most respected life science ... the human capital sector. , “It is a great honor for Slone Partners to ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):